MedTrace Logo

Remission in Rheumatoid Arthritis in the Asian-Pacific Region

NCT03365856 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2017-12-07

No results posted yet for this study

Summary

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.

Conditions

Interventions

OTHER

observational study

as clinical practice

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-03-01
Completion
2018-06-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365856 on ClinicalTrials.gov